USCoreR4 Implementation Guide CI Build

This is the Continuous Integration Build of the USCoreR4 Implementation Guide, based on FHIR Version 3.6.0. See the Directory of published versions

Defining URL:http://hl7.org/fhir/us/core-r4/ValueSet/us-core-cvx
Version:2.0.0
Name:Vaccine_Administered_Value_Set_CVX
Definition:

This identifies the vaccine substance administered - CVX codes

Publisher:HL7 US Realm Steering Committee
OID:2.16.840.1.113883.3.88.12.80.22(for OID based terminology systems)

Vaccine Administered Value Set (CVX)

This identifies the vaccine substance administered - CVX codes

This value set includes codes from the following code systems:

  • Include all codes defined in http://hl7.org/fhir/sid/cvx

Expansion

This value set contains 195 concepts

All codes from system http://hl7.org/fhir/sid/cvx

CodeDisplay
143Adenovirus types 4 and 7
54adenovirus, type 4
55adenovirus, type 7
82adenovirus, unspecified formulation
24anthrax
181anthrax immune globulin
801AS03 Adjuvant
19BCG
27botulinum antitoxin
173cholera, BivWC
174cholera, live attenuated
26cholera, unspecified formulation
172cholera, WC-rBS
29CMVIG
56dengue fever
12diphtheria antitoxin
28DT (pediatric)
20DTaP
106DTaP, 5 pertussis antigens
107DTaP, unspecified formulation
146DTaP,IPV,Hib,HepB
110DTaP-Hep B-IPV
50DTaP-Hib
120DTaP-Hib-IPV
130DTaP-IPV
132DTaP-IPV-HIB-HEP B, historical
170DTAP/IPV/HIB - non-US
01DTP
22DTP-Hib
102DTP-Hib-Hep B
57hantavirus
30HBIG
52Hep A, adult
154Hep A, IG
169Hep A, live attenuated
83Hep A, ped/adol, 2 dose
84Hep A, ped/adol, 3 dose
31Hep A, pediatric, unspecified formulation
85Hep A, unspecified formulation
104Hep A-Hep B
193Hep A-Hep B, pediatric/adolescent
08Hep B, adolescent or pediatric
42Hep B, adolescent/high risk infant
43Hep B, adult
44Hep B, dialysis
45Hep B, unspecified formulation
58Hep C
59Hep E
189HepB-CpG
60herpes simplex 2
47Hib (HbOC)
46Hib (PRP-D)
49Hib (PRP-OMP)
48Hib (PRP-T)
17Hib, unspecified formulation
51Hib-Hep B
61HIV
118HPV, bivalent
62HPV, quadrivalent
137HPV, unspecified formulation
165HPV9
86IG
14IG, unspecified formulation
87IGIV
160Influenza A monovalent (H5N1), ADJUVANTED-2013
151influenza nasal, unspecified formulation
123influenza, H5N1-1203
135Influenza, high dose seasonal
153Influenza, injectable, MDCK, preservative free
171Influenza, injectable, MDCK, preservative free, quadrivalent
186Influenza, injectable, MDCK, quadrivalent, preservative
158influenza, injectable, quadrivalent
150influenza, injectable, quadrivalent, preservative free
161Influenza, injectable,quadrivalent, preservative free, pediatric
166influenza, intradermal, quadrivalent, preservative free
111influenza, live, intranasal
149influenza, live, intranasal, quadrivalent
155influenza, recombinant, injectable, preservative free
185influenza, recombinant, quadrivalent,injectable, preservative free
141Influenza, seasonal, injectable
140Influenza, seasonal, injectable, preservative free
144influenza, seasonal, intradermal, preservative free
15influenza, split (incl. purified surface antigen)
168influenza, trivalent, adjuvanted
88influenza, unspecified formulation
16influenza, whole
10IPV
134Japanese Encephalitis IM
39Japanese encephalitis SC
129Japanese Encephalitis, unspecified formulation
63Junin virus
64leishmaniasis
65leprosy
66Lyme disease
04M/R
67malaria
05measles
68melanoma
191meningococcal A polysaccharide (non-US)
192meningococcal AC polysaccharide (non-US)
108meningococcal ACWY, unspecified formulation
163meningococcal B, OMV
162meningococcal B, recombinant
164meningococcal B, unspecified
103meningococcal C conjugate
148Meningococcal C/Y-HIB PRP
147meningococcal MCV4, unspecified formulation
136Meningococcal MCV4O
114meningococcal MCV4P
32meningococcal MPSV4
167meningococcal, unknown serogroups
03MMR
94MMRV
07mumps
127Novel influenza-H1N1-09
128Novel Influenza-H1N1-09, all formulations
125Novel Influenza-H1N1-09, nasal
126Novel influenza-H1N1-09, preservative-free
02OPV
179OPV ,monovalent, unspecified
178OPV bivalent
182OPV, Unspecified
69parainfluenza-3
177PCV10
11pertussis
23plague
133Pneumococcal conjugate PCV 13
100pneumococcal conjugate PCV 7
152Pneumococcal Conjugate, unspecified formulation
33pneumococcal polysaccharide PPV23
109pneumococcal, unspecified formulation
89polio, unspecified formulation
70Q fever
175Rabies - IM Diploid cell culture
176Rabies - IM fibroblast culture
40rabies, intradermal injection
18rabies, intramuscular injection
90rabies, unspecified formulation
72rheumatic fever
159Rho(D) - Unspecified formulation
157Rho(D) -IG IM
156Rho(D)-IG
73Rift Valley fever
34RIG
119rotavirus, monovalent
116rotavirus, pentavalent
74rotavirus, tetravalent
122rotavirus, unspecified formulation
71RSV-IGIV
93RSV-MAb
145RSV-MAb (new)
06rubella
38rubella/mumps
76Staphylococcus bacterio lysate
138Td (adult)
09Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
113Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
139Td(adult) unspecified formulation
115Tdap
180tetanus immune globulin
35tetanus toxoid, adsorbed
142tetanus toxoid, not adsorbed
112tetanus toxoid, unspecified formulation
77tick-borne encephalitis
13TIG
98TST, unspecified formulation
95TST-OT tine test
96TST-PPD intradermal
97TST-PPD tine test
78tularemia vaccine
190Typhoid conjugate vaccine (TCV)
25typhoid, oral
41typhoid, parenteral
53typhoid, parenteral, AKD (U.S. military)
91typhoid, unspecified formulation
101typhoid, ViCPs
131typhus, historical
75vaccinia (smallpox)
105vaccinia (smallpox) diluted
79vaccinia immune globulin
21varicella
81VEE, inactivated
80VEE, live
92VEE, unspecified formulation
36VZIG
117VZIG (IND)
37yellow fever
183Yellow fever vaccine - alt
184Yellow fever, unspecified formulation
121zoster live
187zoster recombinant
188zoster, unspecified formulation
998no vaccine administered
99RESERVED - do not use
999unknown